APPLICATION
ANDA062468
TYPE
ANDA
ORIGINAL APPROVAL
1985-07-03
LATEST ACTION
2000-10-16
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
C-SOLVE-2Discontinued
ERYTHROMYCIN 2% · SOLUTION · TOPICAL
Approval history
2000-10-16Manufacturing (CMC) · Supplement 9AP
2000-10-16Manufacturing (CMC) · Supplement 8AP
2000-07-11Manufacturing (CMC) · Supplement 10AP
1992-10-27Manufacturing (CMC) · Supplement 5AP
1992-07-10Labeling · Supplement 7AP
1991-11-29Manufacturing (CMC) · Supplement 4AP
1991-11-29Labeling · Supplement 2AP
1991-11-29Manufacturing (CMC) · Supplement 3AP
1985-07-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.